Close
Close
Treatment Database
(R)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dien-1-yl) butanamide
Trade Name not avaiable
Orphan Indication Amyotrophic lateral sclerosis
USA Market Approval
USA Designation Date 27-07-2017
Sponsor BioElectron Technology Corporation
350 North Bernardo Avenue
Mountain View, California, 94043
More about Amyotrophic lateral sclerosis
Free Newsletter
Treatment News
Related Videos
by Abidemi Uruejoma
404 views
by Abidemi Uruejoma
1,005 views
by Abidemi Uruejoma
11,471 views
by Abidemi Uruejoma
9,844 views